Joint EMA/EORTC Workshop
February 29, 2024
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) are jointly organising a workshop called “How can patient-reported outcomes (PRO) and health-related quality of life (HRQoL) data inform regulatory decisions?”
This workshop will bring together international experts from academia, learned societies, patients, regulatory agencies, health technology assessment bodies, and industry.
Date: Thursday, 29 February 2024
Location: European Medicines Agency, Amsterdam
Next events
EORTC Brain Tumour Group Spring Meeting
February 21
EORTC HQ, Brussels, Belgium
EORTC Melanoma Group Spring Meeting 2025
March 20 - March 21
Frankfurt, Germany
EORTC Lymphoma Group Spring Meeting 2025
March 21
Copenhagen, Denmark
ECHNO 2025
March 26 - March 29
Amsterdam, Netherlands
EORTC Quality of Life Group Spring Meeting 2025
March 27 - March 28
Rotterdam, Netherlands